INTREPID POTASH INC (IPI) Stock Fundamental Analysis
USA - NYSE:IPI - US46121Y2019 - Common Stock
30.5499 USD
+0.07 (+0.23%)
IPI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. IPI has a great financial health rating, but its profitability evaluates not so good. IPI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IPI was profitable.
In the past year IPI had a positive cash flow from operations.
In multiple years IPI reported negative net income over the last 5 years.
In the past 5 years IPI always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -33.11%, IPI is doing worse than 90.36% of the companies in the same industry.
The Return On Equity of IPI (-41.55%) is worse than 79.52% of its industry peers.
IPI's Return On Invested Capital of 0.66% is on the low side compared to the rest of the industry. IPI is outperformed by 78.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.11% | ||
| ROE | -41.55% | ||
| ROIC | 0.66% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 1.68%, IPI is not doing good in the industry: 74.70% of the companies in the same industry are doing better.
Looking at the Gross Margin, with a value of 15.54%, IPI is doing worse than 73.49% of the companies in the same industry.
In the last couple of years the Gross Margin of IPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.68% | ||
| PM (TTM) | N/A | ||
| GM | 15.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IPI is destroying value.
IPI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IPI has less shares outstanding
IPI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.43 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.43, IPI is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
IPI has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
IPI's Debt to FCF ratio of 0.05 is amongst the best of the industry. IPI outperforms 98.80% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that IPI is not too dependend on debt financing.
IPI has a better Debt to Equity ratio (0.00) than 98.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 2.43 |
ROIC/WACC0.08
WACC8.79%
2.3 Liquidity
A Current Ratio of 5.28 indicates that IPI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.28, IPI belongs to the top of the industry, outperforming 95.18% of the companies in the same industry.
A Quick Ratio of 2.78 indicates that IPI has no problem at all paying its short term obligations.
IPI has a better Quick ratio (2.78) than 87.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.28 | ||
| Quick Ratio | 2.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 151.75% over the past year.
IPI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.91%.
IPI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.96% yearly.
EPS 1Y (TTM)151.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%850%
Revenue 1Y (TTM)11.91%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%15.18%
3.2 Future
IPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.08% yearly.
Based on estimates for the next years, IPI will show a small growth in Revenue. The Revenue will grow by 0.32% on average per year.
EPS Next Y377.19%
EPS Next 2Y50.27%
EPS Next 3Y24.08%
EPS Next 5YN/A
Revenue Next Year2.36%
Revenue Next 2Y-0.1%
Revenue Next 3Y0.32%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 51.78, which means the current valuation is very expensive for IPI.
Based on the Price/Earnings ratio, IPI is valued a bit more expensive than 62.65% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.90, IPI is valued quite expensively.
A Price/Forward Earnings ratio of 263.02 indicates a quite expensive valuation of IPI.
Based on the Price/Forward Earnings ratio, IPI is valued a bit more expensive than 69.88% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IPI to the average of the S&P500 Index (23.36), we can say IPI is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.78 | ||
| Fwd PE | 263.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IPI is valued a bit cheaper than 79.52% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IPI is valued a bit cheaper than the industry average as 75.90% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.81 | ||
| EV/EBITDA | 7.23 |
4.3 Compensation for Growth
IPI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IPI's earnings are expected to grow with 24.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y50.27%
EPS Next 3Y24.08%
5. Dividend
5.1 Amount
IPI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:IPI (10/7/2025, 2:55:02 PM)
30.5499
+0.07 (+0.23%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners57.88%
Inst Owner Change0%
Ins Owners2%
Ins Owner Change-1.25%
Market Cap406.92M
Analysts42.22
Price Target23.46 (-23.21%)
Short Float %3.56%
Short Ratio2.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)598.3%
Min EPS beat(2)324.33%
Max EPS beat(2)872.28%
EPS beat(4)2
Avg EPS beat(4)261.99%
Min EPS beat(4)-142.02%
Max EPS beat(4)872.28%
EPS beat(8)2
Avg EPS beat(8)-89.19%
EPS beat(12)2
Avg EPS beat(12)-70.18%
EPS beat(16)3
Avg EPS beat(16)-55.32%
Revenue beat(2)2
Avg Revenue beat(2)21.74%
Min Revenue beat(2)17.42%
Max Revenue beat(2)26.05%
Revenue beat(4)4
Avg Revenue beat(4)20.54%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)22.42%
Revenue beat(12)11
Avg Revenue beat(12)21.59%
Revenue beat(16)15
Avg Revenue beat(16)18.93%
PT rev (1m)0%
PT rev (3m)9.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)247.06%
EPS NY rev (1m)183.91%
EPS NY rev (3m)183.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.78 | ||
| Fwd PE | 263.02 | ||
| P/S | 1.44 | ||
| P/FCF | 15.81 | ||
| P/OCF | 7.52 | ||
| P/B | 0.84 | ||
| P/tB | 0.88 | ||
| EV/EBITDA | 7.23 |
EPS(TTM)0.59
EY1.93%
EPS(NY)0.12
Fwd EY0.38%
FCF(TTM)1.93
FCFY6.32%
OCF(TTM)4.06
OCFY13.29%
SpS21.22
BVpS36.32
TBVpS34.69
PEG (NY)0.14
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.11% | ||
| ROE | -41.55% | ||
| ROCE | 0.84% | ||
| ROIC | 0.66% | ||
| ROICexc | 0.78% | ||
| ROICexgc | 0.81% | ||
| OM | 1.68% | ||
| PM (TTM) | N/A | ||
| GM | 15.54% | ||
| FCFM | 9.11% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 71.13% | ||
| Cap/Sales | 10.03% | ||
| Interest Coverage | 10.72 | ||
| Cash Conversion | 121.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.28 | ||
| Quick Ratio | 2.78 | ||
| Altman-Z | 2.43 |
F-Score4
WACC8.79%
ROIC/WACC0.08
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)151.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%850%
EPS Next Y377.19%
EPS Next 2Y50.27%
EPS Next 3Y24.08%
EPS Next 5YN/A
Revenue 1Y (TTM)11.91%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%15.18%
Revenue Next Year2.36%
Revenue Next 2Y-0.1%
Revenue Next 3Y0.32%
Revenue Next 5YN/A
EBIT growth 1Y129.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1883.15%
EBIT Next 3Y140.86%
EBIT Next 5YN/A
FCF growth 1Y159.44%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y21.52%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%